相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Pharmacist Transition-of-Care Services Improve Patient Satisfaction and Decrease Hospital Readmissions
Katherine L. March et al.
JOURNAL OF PHARMACY PRACTICE (2022)
Disparities in Mortality and Health Care Utilization for 460,851 Hospitalized Patients with Cirrhosis and Hepatic Encephalopathy
Harry Trieu et al.
DIGESTIVE DISEASES AND SCIENCES (2021)
Burdensome Transitions of Care for Patients with End-Stage Liver Disease and Their Caregivers
Nneka N. Ufere et al.
DIGESTIVE DISEASES AND SCIENCES (2021)
Impact of spontaneous splenorenal shunt on liver volume and long-term survival of liver cirrhosis
Fangfang Yi et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2021)
Gut Microbiota Modulation and Fecal Transplantation: An Overview on Innovative Strategies for Hepatic Encephalopathy Treatment
Ramzi Hassouneh et al.
JOURNAL OF CLINICAL MEDICINE (2021)
Fecal Microbiota Transplant in Cirrhosis Reduces Gut Microbial Antibiotic Resistance Genes: Analysis of Two Trials
Jasmohan S. Bajaj et al.
HEPATOLOGY COMMUNICATIONS (2021)
Predicting 30-Day Hospital Readmission Risk in a National Cohort of Patients with Cirrhosis
Jejo D. Koola et al.
DIGESTIVE DISEASES AND SCIENCES (2020)
The Medicare Part D Coverage Gap, Prescription Use, and Expenditures
Aig Unuigbe
MEDICAL CARE RESEARCH AND REVIEW (2020)
In inpatients with cirrhosis opioid use is common and associated with length of stay and persistent use post-discharge
Andrew M. Moon et al.
PLOS ONE (2020)
Medicare's Care Management Codes Might Not Support Primary Care As Expected
Sumit D. Agarwal et al.
HEALTH AFFAIRS (2020)
Acceptance and use of a smartphone application in cirrhosis
Jeremy Louissaint et al.
LIVER INTERNATIONAL (2020)
Psychological Burden of Hepatic Encephalopathy on Patients and Caregivers
Núria Fabrellas et al.
Clinical and Translational Gastroenterology (2020)
A retrospective study of drug utilization and hospital readmissions among Medicare patients with hepatic encephalopathy
Aisha Vadhariya et al.
MEDICINE (2020)
S0988 Health Outcomes in Patients With Hepatic Encephalopathy Managed Through Telemedicine and a Specialized Pharmacy Team
Jennifer Wells et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2020)
Hepatic encephalopathy increases the risk of hip fracture: a nationwide cohort study
Kuang-Ting Yeh et al.
BMC MUSCULOSKELETAL DISORDERS (2020)
ESPEN practical guideline: Clinical nutrition in liver disease
Stephan C. Bischoff et al.
CLINICAL NUTRITION (2020)
Nationwide estimates and risk factors of hospital readmission in patients with cirrhosis in the United States
Abdel-Aziz Shaheen et al.
LIVER INTERNATIONAL (2019)
Targets to improve quality of care for patients with hepatic encephalopathy: data from a multi-centre cohort
Jasmohan S. Bajaj et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2019)
Predictive models of mortality and hospital readmission of patients with decompensated liver cirrhosis
Rui Gaspar et al.
DIGESTIVE AND LIVER DISEASE (2019)
Fecal Microbial Transplant Capsules Are Safe in Hepatic Encephalopathy: A Phase 1, Randomized, Placebo-Controlled Trial
Jasmohan S. Bajaj et al.
HEPATOLOGY (2019)
Cirrhosis as a Comorbidity in Conditions Subject to the Hospital Readmissions Reduction Program
Russell Rosenblatt et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2019)
A transition care coordinator model reduces hospital readmissions and costs
Sunil Kripalani et al.
CONTEMPORARY CLINICAL TRIALS (2019)
Health-related quality of life in patients with compensated and decompensated liver cirrhosis
Christian Labenz et al.
EUROPEAN JOURNAL OF INTERNAL MEDICINE (2019)
Cost-Related Medication Nonadherence Among Older Adults: Findings From a Nationally Representative Sample
Green C. Chung et al.
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY (2019)
Improving cirrhosis care: The potential for telemedicine and mobile health technologies
Matthew Jonathon Stotts et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2019)
Waste in the US Health Care System: Estimated Costs and Potential for Savings
William H. Shrank et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2019)
Burden and Cost of Gastrointestinal, Liver, and Pancreatic Diseases in the United States: Update 2018
Anne F. Peery et al.
GASTROENTEROLOGY (2019)
Effectiveness of mailed letters to improve medication adherence among Medicare Advantage Plan participants with chronic conditions
Amanda Mann et al.
PATIENT PREFERENCE AND ADHERENCE (2019)
Improving Outcomes After Hospitalization: A Prospective Observational Multicenter Evaluation of Care Coordination Strategies for Reducing 30-Day Readmissions to Maryland Hospitals
Erik H. Hoyer et al.
JOURNAL OF GENERAL INTERNAL MEDICINE (2018)
Effects of a pharmacist-driven intervention program on hospital readmissions
Mariel T. Shull et al.
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY (2018)
Increased Morbidity and Mortality Associated with Falls Among Patients with Cirrhosis
Ghideon Ezaz et al.
AMERICAN JOURNAL OF MEDICINE (2018)
Multiple bacterial infections increase the risk of hepatic encephalopathy in patients with cirrhosis
Lan-Ting Yuan et al.
PLOS ONE (2018)
Fecal Microbiota Transplant From a Rational Stool Donor Improves Hepatic Encephalopathy: A Randomized Clinical Trial
Jasmohan S. Bajaj et al.
HEPATOLOGY (2017)
The patient buddy app can potentially prevent hepatic encephalopathy-related readmissions
Dinesh Ganapathy et al.
LIVER INTERNATIONAL (2017)
Medication beliefs predict medication adherence in ambulatory patients with decompensated cirrhosis
Kelly L. Hayward et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2017)
Hospital readmissions in decompensated cirrhotics: Factors pointing toward a prevention strategy
Siamak M. Seraj et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2017)
Prognostic value of sarcopenia in patients with liver cirrhosis: A systematic review and meta-analysis
Gaeun Kim et al.
PLOS ONE (2017)
An educational tool for the prophylaxis of hepatic encephalopathy
Maria Garrido et al.
BMJ OPEN GASTROENTEROLOGY (2017)
A New Look at Precipitants of Overt Hepatic Encephalopathy in Cirrhosis
Ganesh Pantham et al.
DIGESTIVE DISEASES AND SCIENCES (2017)
Association of Provider Communication and Discharge Instructions on Lower Readmissions
Jordan P. Mitchell
Journal for Healthcare Quality (2016)
Prevalence of medication discrepancies in patients with cirrhosis: a pilot study
Kelly L. Hayward et al.
BMC GASTROENTEROLOGY (2016)
Building Effective Quality Improvement Programs for Liver Disease: A Systematic Review of Quality Improvement Initiatives
Elliot B. Tapper
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2016)
Rates of and Reasons for Hospital Readmissions in Patients With Cirrhosis: A Multistate Population-based Cohort Study
Elliot B. Tapper et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2016)
Evaluation and Management of Hepatic Encephalopathy: Current Status and Future Directions
Duminda Suraweera et al.
GUT AND LIVER (2016)
Being an informal caregiver for a relative with liver cirrhosis and overt hepatic encephalopathy: a phenomenological study
Patrizia Kunzler-Heule et al.
JOURNAL OF CLINICAL NURSING (2016)
The impact on hospital resource utilisation of treatment of hepatic encephalopathy with rifaximin-α
James G. Orr et al.
LIVER INTERNATIONAL (2016)
Treatment of Patients with Cirrhosis
Phillip S. Ge et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
The Epidemiology of Cirrhosis in the United States A Population-based Study
Steven Scaglione et al.
JOURNAL OF CLINICAL GASTROENTEROLOGY (2015)
A Patient Navigator Intervention to Reduce Hospital Readmissions among High-Risk Safety-Net Patients: A Randomized Controlled Trial
Richard B. Balaban et al.
JOURNAL OF GENERAL INTERNAL MEDICINE (2015)
Impact of an Innovative Inpatient Patient Navigator Program on Length of Stay and 30-Day Readmission
Janice L. Kwan et al.
JOURNAL OF HOSPITAL MEDICINE (2015)
Improvement in survival associated with embolisation of spontaneous portosystemic shunt in patients with recurrent hepatic encephalopathy
J. An et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2014)
Transitional Care Management Reimbursement to Reduce COPD Readmission
Shreya Kangovi et al.
CHEST (2014)
Rifaximin Is Safe and Well Tolerated for Long-term Maintenance of Remission From Overt Hepatic Encephalopathy
Kevin D. Mullen et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2014)
Hepatic Encephalopathy in Chronic Liver Disease: 2014 Practice Guideline by the American Association for the Study of Liver Diseases and the European Association for the Study of the Liver
Hendrik Vilstrup et al.
HEPATOLOGY (2014)
Embolization of large spontaneous portosystemic shunts for refractory hepatic encephalopathy: A multicenter survey on safety and efficacy
Wim Laleman et al.
HEPATOLOGY (2013)
Characteristics of Hospitals Receiving Penalties Under the Hospital Readmissions Reduction Program
Karen E. Joynt et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2013)
Hospital Readmissions Among Patients With Decompensated Cirrhosis
Michael L. Volk et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2012)
Cognitive dysfunction in cirrhosis is associated with falls: A prospective study
German Soriano et al.
HEPATOLOGY (2012)
Early Hospital Readmission is a Predictor of One-Year Mortality in Community-Dwelling Older Medicare Beneficiaries
Hillary D. Lum et al.
JOURNAL OF GENERAL INTERNAL MEDICINE (2012)
The Multi-Dimensional Burden of Cirrhosis and Hepatic Encephalopathy on Patients and Caregivers
Jasmohan S. Bajaj et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2011)
Review article: the modern management of hepatic encephalopathy
J. S. Bajaj
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2010)
Rifaximin Treatment in Hepatic Encephalopathy
Nathan M. Bass et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Natural history and prognostic indicators of survival in cirrhosis: A systematic review of 118 studies
G D'Amico et al.
JOURNAL OF HEPATOLOGY (2006)
High prevalence of spontaneous portal-systemic shunts in persistent hepatic encephalopathy: A case-control study
O Riggio et al.
HEPATOLOGY (2005)
分享论文
